Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMED
4651
PUT
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $506K | ﹤0.01% |
50,000
+600
| +1% | +$7.04K |
|
|
SRCL
4652
CALL
DELISTED
Stericycle Inc
SRCL
| $505K | ﹤0.01% |
4,000
-3,600
| -47% | -$419K |
|
|
NYRT
4653
PUT
DELISTED
New York REIT, Inc.
NYRT
| $505K | ﹤0.01% |
+5,000
| New | +$502K |
|
4654
PUT
FirstEnergy
FE
$27.5B
| $504K | ﹤0.01% |
+14,000
| New | +$471K |
|
4655
CALL
Jones Lang LaSalle
JLL
$16.7B
| $504K | ﹤0.01% |
4,300
+3,800
| +760% | +$460K |
|
4656
Weis Markets
WMK
$1.86B
| $504K | ﹤0.01% |
11,180
-2,558
| -19% | -$105K |
|
|
CEW
4657
WisdomTree Emerging Currency Strategy Fund
CEW
$17.9M
| $502K | ﹤0.01% |
28,298
-275,817
| -91% | -$4.63M |
|
4658
PUT
Trane Technologies
TT
$106B
| $502K | ﹤0.01% |
8,100
-4,800
| -37% | -$262K |
|
4659
CALL
Golar LNG
GLNG
$5.13B
| $501K | ﹤0.01% |
+27,900
| New | +$476K |
|
4660
Globant
GLOB
$1.61B
| $501K | ﹤0.01% |
+16,237
| New | +$489K |
|
4661
CALL
Jabil
JBL
$35.8B
| $501K | ﹤0.01% |
26,000
-82,400
| -76% | -$1.66M |
|
4662
CALL
Viavi Solutions
VIAV
$9.66B
| $500K | ﹤0.01% |
72,900
+37,900
| +108% | +$228K |
|
|
MACK
4663
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $499K | ﹤0.01% |
7,586
+3,911
| +106% | +$204K |
|
|
ADT
4664
PUT
DELISTED
ADT Corp
ADT
| $499K | ﹤0.01% |
12,100
-65,900
| -84% | -$2.31M |
|
|
NWY
4665
DELISTED
New York & Co Inc
NWY
| $498K | ﹤0.01% |
125,815
+105,954
| +533% | +$263K |
|
4666
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $497K | ﹤0.01% |
8,778
-242
| -3% | -$12.6K |
|
|
YDKN
4667
DELISTED
Yadkin Financial Corporation
YDKN
| $496K | ﹤0.01% |
20,936
+10,726
| +105% | +$242K |
|
4668
Vanguard S&P 500 Growth ETF
VOOG
$27.2B
| $495K | ﹤0.01% |
+28,548
| New | +$469K |
|
|
IRBT
4669
CALL
DELISTED
iRobot
IRBT
| $494K | ﹤0.01% |
14,000
-18,700
| -57% | -$609K |
|
4670
ProShares Ultra Consumer Staples
UGE
$12M
| $494K | ﹤0.01% |
52,740
-194,112
| -79% | -$1.64M |
|
|
CSOD
4671
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $492K | ﹤0.01% |
15,000
+13,700
| +1,054% | +$413K |
|
4672
Horace Mann Educators
HMN
$2.11B
| $491K | ﹤0.01% |
15,496
+1,009
| +7% | +$30.9K |
|
4673
PUT
United Parks & Resorts
PRKS
$2.12B
| $491K | ﹤0.01% |
23,300
-112,400
| -83% | -$2.1M |
|
|
TMHC
4674
DELISTED
Taylor Morrison
TMHC
| $490K | ﹤0.01% |
34,710
+7,615
| +28% | +$101K |
|
|
VRTU
4675
DELISTED
Virtusa Corporation
VRTU
| $490K | ﹤0.01% |
13,078
-7,716
| -37% | -$292K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.